Tuesday, July 8, 2025
12.7 C
London
HomeFinTechCyclopharm: Completes $30M placement

Cyclopharm: Completes $30M placement

Date:

Mastercard and Pay4You Unite for Enhanced Spend Management Solutions

A Game-Changing Partnership to Transform Financial Oversight for BusinessesHighlights:...

EPC Urges Directory Service Providers to Collaborate on VOP Scheme

Enhancing the Future of Payments: A Call for Collaboration...

Five More Belgian Banks Join the European Payments Initiative

Enhancing Collaboration in the Payment Landscape Across EuropeHighlights: Five...
  • Cyclopharm (CYC) has completed a share placement to raise $30 million
  • Roughly 11.5 million new fully paid ordinary shares offered at $2.60 per share
  • Funds raised will primarily used to finance activities to accelerate Cyclopharm’s expansion into the U.S. market, pushing its Technegas product
  • The company will also conducting a non-underwritten share purchase plan offer to existing eligible shareholders who have a registered address in Australia
  • The placement shares expected to issued and commence trading on the ASX on February 1, 2021
  • Cyclopharm shares are up 3.06 per cent, trading at $3.03

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories